[Symptomatic hyperlactemia in patients infected with the human immunodeficiency virus treated with nucleoside analogs].
Lozano
F
F
Ramayo
E
E
Corzo
J E
JE
Gómez-Mateos
J
J
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D016049:Didanosine / Q000009:adverse effects; D005260:Female; D015658:HIV Infections / Q000097:blood* / Q000188:drug therapy; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors*; D006801:Humans; D019344:Lactic Acid / Q000097:blood*; D019259:Lamivudine / Q000009:adverse effects; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D015215:Zidovudine / Q000009:adverse effects
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D019344:Lactic Acid; D015215:Zidovudine; D054303:HIV Reverse Transcriptase; D016049:Didanosine